Akzo Nobel N.V. Website

Akzo Nobel N.V.

ENXTAM-AKZA

Basic

  • Market Cap

    €9,947.71M

  • EV

    €14.21B

  • Shares Out

    170.63M

  • Revenue

    €10.65B

  • Employees

    35,500

Margins

  • Gross

    40.74%

  • EBITDA

    13.14%

  • Operating

    10.7%

  • Pre-Tax

    8.31%

  • Net

    4.97%

  • FCF

    6.88%

Returns (5Yr Avg)

  • ROA

    7.74%

  • ROTA

    44.83%

  • ROE

    17.96%

  • ROCE

    9.31%

  • ROIC

    6.21%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €74.44

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €1,098M

  • Net Debt

    €4,031M

  • Debt/Equity

    1.07

  • EBIT/Interest

    5.62

Growth (CAGR)

  • Rev 3Yr

    6.83%

  • Rev 5Yr

    2.83%

  • Rev 10Yr

    -3.04%

  • Dil EPS 3Yr

    -7.06%

  • Dil EPS 5Yr

    -35.75%

  • Dil EPS 10Yr

    -1.31%

  • Rev Fwd 2Yr

    1.83%

  • EBITDA Fwd 2Yr

    8.21%

  • EPS Fwd 2Yr

    24.66%

  • EPS LT Growth Est

    18.56%

Dividends

  • Yield

  • Payout

    63.21%

  • DPS

    €1.98

  • DPS Growth 3Yr

    0.51%

  • DPS Growth 5Yr

    1.41%

  • DPS Growth 10Yr

    1.96%

  • DPS Growth Fwd 2Yr

    2.62%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Total Revenues

9,276

8,530

9,587

10,846

10,668

10,651

Total Revenues % Chg.

0.2%

-8%

12.4%

13.1%

-1.6%

-3%

Cost of Goods Sold, Total

5,314

4,745

5,683

6,923

6,434

6,312

Gross Profit

3,962

3,785

3,904

3,923

4,234

4,339

Selling General & Admin Expenses, Total

2,833

2,579

2,610

2,939

2,962

2,992

R&D Expenses

262

238

230

258

270

270

Other Operating Expenses

5

5

-25

-60

-63

Other Operating Expenses, Total

3,100

2,822

2,815

3,197

3,172

3,199

Operating Income

862

963

1,089

726

1,062

1,140

Interest Expense, Total

-90

-62

-74

-106

-193

-203

Interest And Investment Income

17

15

36

69

73

Net Interest Expenses

-73

-62

-59

-70

-124

-130

Income (Loss) On Equity Invest.

20

25

26

18

27

27

Currency Exchange Gains (Loss)

-24

-21

-65

-128

-128

Other Non Operating Income (Expenses)

-7

13

-7

22

EBT, Excl. Unusual Items

785

919

1,035

622

830

931

Gain (Loss) On Sale Of Assets

Asset Writedown

Legal Settlements

70

Other Unusual Items

-20

-46

-46

EBT, Incl. Unusual Items

785

919

1,105

602

784

885

Income Tax Expense

230

241

246

214

296

308

Earnings From Continuing Operations

555

678

859

388

488

577

Earnings Of Discontinued Operations

22

-7

6

-10

-5

-5

Minority Interest

-38

-41

-36

-26

-41

-43

Net Income

539

630

829

352

442

529

Net Income to Common Incl Extra Items

539

630

829

352

442

529

Net Income to Common Excl. Extra Items

517

637

823

362

447

534

Total Shares Outstanding

199.6

189.9

178.9

170.4

170.6

170.6

Weighted Avg. Shares Outstanding

213.1

191.4

185

174.7

170.6

170.5

Weighted Avg. Shares Outstanding Dil

213.8

192.1

185.7

175.3

171.3

171.3

EPS

2.5

3.3

4.5

2

2.6

3.1

EPS Diluted

2.5

3.3

4.5

2

2.6

3.1

EBITDA

1,117

1,225

1,346

996

1,320

1,400

Effective Tax Rate

29.3%

26.2%

22.3%

35.5%

37.8%

34.8%